8-K - MAIA Biotechnology, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

MAIA Biotechnology, Inc. awarded one-time bonus payments of $312,610 to CEO Vlad Vitoc and $50,000 to Head of Finance Jeffrey Himmelreich on March 31, 2026, in connection with the company’s recent capital raise.

Key Takeaways

1CEO Vlad Vitoc received a $312,610 one-time bonus for contributions to the recent capital raise — reflects direct linkage between executive compensation and financing success.

2Head of Finance Jeffrey Himmelreich received a $50,000 one-time bonus — signals recognition of finance leadership in capital markets execution.

3Bonuses were approved by the Board of Directors on March 27, 2026, and paid on March 31, 2026 — confirms timely, board-authorized compensation action.

4Payment rationale is explicitly tied to the company’s recent capital raise — no other performance criteria or ongoing arrangements disclosed.

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** On March 27

Management Change

$312.6K$50.0K

9.01

Financial Statements and Exhibits.** (d) Exhibits. | Exhibit No. | | Description | |---|---|---| | 104 | | Cover Page Interactive Data File (embedded within the

Exhibits Only

Executive & Director Changes

Vlad Vitoc

Chief Executive Officer

Awarded one-time bonus

Effective: 2026-03-31

Efforts in connection with the Company’s recent capital raise

Jeffrey Himmelreich

Head of Finance

Awarded one-time bonus

Effective: 2026-03-31

Efforts in connection with the Company’s recent capital raise

Exhibits (1)

8-K